Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease

Neurobiology of Disease

Volumn 8, Issue 3, 2001, Pages 433-446

  De Almeida, L P ^a,b   Zala, D ^a   Aebischer, P ^a,c   Deglon N ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c EPFL   (Switzerland)

Author keywords

Ciliary neurotrophic factor; Gene therapy; Huntington's disease; Lentiviral vector; Quinolinic acid lesion model

Indexed keywords

APOMORPHINE; BETA GALACTOSIDASE; CILIARY NEUROTROPHIC FACTOR; PHOSPHOGLYCERATE KINASE; PHOSPHOPROTEIN DARPP 32; QUINOLINIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUNTINGTON CHOREA; LENTIVIRINAE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; VIRUS EXPRESSION;

EID: 0034979217     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0388     Document Type: Article

References (81)

1. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF
2. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease
3. Human gene therapy
4. Glial cell line-derived neurotrophic factor attenuates the exitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease
5. Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum
6. Prospectives for cell and gene therapy in Huntington's disease
7. Does impairment of energy metabolism result in exitotoxic neuronal death in neurodegenerative illnesses?
8. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
9. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer
10. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus
11. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway
12. Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioural improvements in a 6-OHDA model of Parkinson's disease using GDNF
13. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
14. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test
15. Regulation of nociceptin/orphanin FQ gene expression by neuropoietin cytokines and neurotrophic factors in neurons and astrocytes
16. Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced with lentiviral vectors
17. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease
18. A third-generation lentivirus vector with a conditional packaging system
19. Subset of neurons characterized by the presence of NADPH-diaphorase in substantia innominata
20. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease
21. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease
22. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease
23. The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation
24. Inducible gene expression in the nervous system of transgenic mice
25. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance
26. Mitochondrial defect in Huntington's disease caudate nucleus
27. Systemic administration of ciliary neurotrophic factor induces cachexia in rodents
28. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily
29. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
30. Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus
31. Injury-induced regulation of ciliary neurotrophic factor mRNA in the adult rat brain
32. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development
33. Lentiviral vectors: Regulated gene expression
34. Lentiviral vectors and gene therapy
35. Convection-enhanced gene transfer of adeno-associated viral vector in Parkinsonian monkeys
36. Safety of intrastriatal neurotransplantation for Huntington's disease patients
37. Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible?
38. Lentiviral gene transfer to the nonhuman primate brain
39. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: Implications for gene therapy
40. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
41. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells
42. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons
43. Stable gene transfer to the nervous system using a nonprimate lentiviral vector
44. Restoration of cognitive and motor functions with ciliary neurotrophic factor in a primate model of Huntington's disease
45. Antioxidant treatment protects striatal neurons against excitotoxic insults
46. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid
47. Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease
48. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
49. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
50. Gene transfer vectors derived from equine infectious anemia virus
51. Total number of neurons in the neostriatum, pallidal, subthalamic, and substantia nigra nuclei of the rat basal ganglia: A stereological study using the Cavalieri and optical disector methods
52. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
53. Efficient lentiviral transduction of liver requires cell cycling in vivo
54. Influence of promoter and WHV posttranscriptional regulatory element on AAV-mediated transgene expression in the rat brain
55. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors
56. Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor
57. Behavioral abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
58. Gene transfer technology in therapy: Current applications and future goals
59. Modifying the host range properties of retroviral vectors
60. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
61. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
62. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids
63. Of neurons and gene chips
64. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
65. Transplantation of fetal porcine striatal cells in Huntington's disease: Preliminary safety and efficacy results
66. Cellular contaminats of adeno-associated virus vector stocks can enhance transduction
67. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome
68. Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy
69. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
70. Gene therapy-promises, problems and prospects
71. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions
72. Huntington disease
73. Cell-type-specific and inducible promoters for vectors in gene therapy as an approach for cell targeting
74. Lentivirus vectors using human and simian immunodeficiency virus elements
75. Anorectic effects of the cytokine, ciliary neurotrophic factor, are mediated by hypothalamic neuropeptide Y: Comparison with leptin
76. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
77. HIV-1 genome nuclear import is mediated by a central DNA flap
78. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
79. Woodschuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
80. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic for motoneurons
81. Development of CNS cholinergic neurons in vitro: Selective effects of CNTF and LIF on neurons from mesencephalic cranial motor nuclei